Wednesday, July 8, 2026

pharma · Acute Schizophrenia · Schizophrenia · RVPH

REVIVA PHARMACEUTICALS HOLDINGS

REVIVA PHARMACEUTICALS HOLDINGS trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Cupertino, USA HQ
20 Employees
Public company Type
RVPH · NYSE Ticker
Company details
Status
Public
HQ
Cupertino, USA
Employees
20
Programs
3
Drugs
1
Patents
28
Intelligence · Clinical Trials

REVIVA PHARMACEUTICALS HOLDINGS clinical trials

Registry index of 3 ClinicalTrials.gov studies linked to REVIVA PHARMACEUTICALS HOLDINGS programs — each row shows trial ID, program name, phase, status, and indication.

REVIVA PHARMACEUTICALS HOLDINGS trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

3 updates

Latest clinical program signals indexed for REVIVA PHARMACEUTICALS HOLDINGS.

  1. Lipoaspiration — Phase 1

    Clinical update
  2. RP5063 — Phase 2

    Clinical update
  3. Brilaroxazine — Phase 3

    Clinical update

Trial registry

3 studies